11 articles for thisTarget

---

The following articles (labelled with PubMed ID or TBD) are for your review

PMID	Data	Article Title	Organization
24944743	3	Discovery and Synthesis of C-Nucleosides as Potential New Anti-HCV Agents.	Biota Scientific Management
24359706	1	Second-generation derivatives of the eukaryotic translation initiation inhibitor pateamine A targeting eIF4A as potential anticancer agents.	St. John'S University
23266186	9	Inhibitory effect of novel somatostatin peptide analogues on human cancer cell growth based on the selective inhibition of DNA polymeraseß.	Kobe Gakuin University
9622545	41	Newly synthesized L-enantiomers of 3'-fluoro-modified beta-2'-deoxyribonucleoside 5'-triphosphates inhibit hepatitis B DNA polymerases but not the five cellular DNA polymerases alpha, beta, gamma, delta, and epsilon nor HIV-1 reverse transcriptase.	Max-Delbr�Ck-Centrum F�R Molekulare Medizin
18852280	8	1,5-benzodiazepines, a novel class of hepatitis C virus polymerase nonnucleoside inhibitors.	Tibotec
19398642	10	GS-9191 is a novel topical prodrug of the nucleotide analog 9-(2-phosphonylmethoxyethyl)guanine with antiproliferative activity and possible utility in the treatment of human papillomavirus lesions.	Gilead Sciences
20516278	10	PSI-7851, a pronucleotide of beta-D-2'-deoxy-2'-fluoro-2'-C-methyluridine monophosphate, is a potent and pan-genotype inhibitor of hepatitis C virus replication.	Pharmasset
18308572	4	Novel azaphilones, kasanosins A and B, which are specific inhibitors of eukaryotic DNA polymerases beta and lambda from Talaromyces sp.	Tokyo University of Science
16854079	57	Benzimidazole derivatives bearing substituted biphenyls as hepatitis C virus NS5B RNA-dependent RNA polymerase inhibitors: structure-activity relationship studies and identification of a potent and highly selective inhibitor JTK-109.	Central Pharmaceutical Research Institute
17573351	2	Enzymatic therapeutic index of acyclovir. Viral versus human polymerase gamma specificity.	The University of Texas